Cindy Lee
About Cindy Lee
Cindy Lee is a Manufacturing Associate specializing in CAR-T cell therapy at Bristol Myers Squibb, with a background in bioengineering and data science.
Current Position at Bristol Myers Squibb
Cindy Lee holds the position of Manufacturing Associate, CAR-T at Bristol Myers Squibb. She has been with the company since August 2020, bringing her expertise in CAR-T cell therapy manufacturing processes to the role. This position involves working in the complex and highly specialized field of CAR-T cell therapy, which is a form of cancer treatment that uses the body's immune system to fight the disease.
Previous Experience as Undergraduate Research Assistant
Cindy Lee has prior experience as an Undergraduate Research Assistant at New Jersey Institute of Technology. She worked in this role for one year, from 2019 to 2020, in Newark, New Jersey. During this time, she was involved in research projects focusing on bioengineering and biomedical engineering, which provided her with foundational experience and knowledge that have been instrumental in her later roles.
Educational Background in Data Science
Cindy Lee completed a Master of Science (MS) degree in Data Science from Rutgers University–New Brunswick. She pursued this advanced degree from 2020 to 2022, spanning two years. During her Masters program, Cindy participated in advanced research initiatives which further enhanced her analytical and technical skills, providing a strong interdisciplinary foundation that she applies in her professional work.
Bachelor's Degree in Bioengineering and Biomedical Engineering
Cindy Lee obtained a Bachelor of Science (BS) degree in Bioengineering and Biomedical Engineering from New Jersey Institute of Technology. During her undergraduate studies, she worked on various research projects related to bioengineering and biomedical engineering. This academic background laid the groundwork for her career in the biotechnology and pharmaceutical industry.
CAR-T Cell Therapy Expertise
Cindy Lee possesses significant expertise in the manufacturing processes of CAR-T cell therapy. This area of specialization involves complex procedures in which T cells are engineered to recognize and combat cancer cells. Her role at Bristol Myers Squibb involves leveraging her combined knowledge in data science and bioengineering to optimize the production of these therapeutic cells.